Dianthus Therapeutics Inc (DNTH)
CapEx to Revenue
23.78%
Quarterly · Period ending:
DNTH CapEx to Revenue
Latest reported23.78%period ending
Latest reported23.78%period ending
DNTH Quarterly CapEx/Revenue (0.00% → 23.78%)
Latest values, visible window
High-resolution chart · PNG
DNTH capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 23.7845% | |
| 2.1598% | |
| 48.5915% | |
| 1.2626% | |
| 23.8342% | |
| 2.0636% | |
| 2.3379% | |
| 1.151% | |
| 0.9125% | |
| 3.6613% | |
| 2.1882% | |
| 15.6926% | |
| 2.1672% | |
| 2.9412% | |
| 2.4681% | |
| 3.9216% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |